Subpart D - DETAILED PROCEDURES FOR NEWBORN BLOOD SPOT CONDITIONS
- § 661.300 - Adrenoleukodystrophy (ALD)
- § 661.310 - Biotinidase Deficiency
- § 661.320 - Congenital Adrenal Hyperplasia (CAH) (Secondary to 21-hydroxylase deficiency)
- § 661.330 - Congenital Hypothyroidism (CH)
- § 661.340 - Cystic Fibrosis (CF)
- § 661.350 - Galactosemia
- § 661.360 - Lysosomal Storage Disorders (LSDs)
- § 661.370 - Amino Acid, Organic Acid and Fatty Acid Oxidation Disorders
- § 661.380 - Severe Combined Immunodeficiency (SCID) and T-Cell Lymphopenia
- § 661.390 - Sickle Cell Disease/Trait and Other Hemoglobinopathies
- § 661.400 - Spinal Muscular Atrophy (SMA)
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.